3.46 USD
↗ 0.21 (6.46%)AT CLOSE (11:59 AM EDT)
Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares
CANFAMEX • USD
3.29
↘ 0.17 (4.91%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
3.29
↘ 0.17 (4.91%)
Market: CLOSED
Open?$3.33
High?$3.47
Low?$3.29
Prev. Close?$3.25
Volume?7.1K
Avg. Volume?N/A
VWAP?$3.33
Bid / Ask
Bid?$3.20 × 200
Ask?$3.46 × 100
Spread?$0.26
Midpoint?$3.33
Valuation & Ratios
Market Cap?7.0M
Shares Out?2.1M
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.
Themes
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...